Social Media Content Creators Driving Parallel Trade for Unapproved Slimming Drug

A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Some experts stated the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.

Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic material and banned related keywords and search suggestions. The company said it was committed to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found communities with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, positive reviews and step-by-step guides for mixing or administering at residence.

Within minutes of joining one group, a seller posted contact information, where the majority of purchases take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Product Details and Pricing

Within these communities, messages display dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram stated it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to potentially significant health risks”.

Charles Ortiz
Charles Ortiz

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on society.